Santa Ana biotech company gets green light from FDA to continue promising new Alzheimer's treatment
Rachel Kim introduces the team behind a promising new Alzheimer's treatment out of a Santa Ana-based NKGen Biotech, which recently got the green light from the FDA to continue their testing. Some patients are showing miraculous signs of recovery.
